Nicole Murphy - 10 Feb 2025 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Pharm Ops and Tech
Signature
/s/ Samuel Ntonme, attorney-in-fact for Nicole Murphy
Issuer symbol
BIIB
Transactions as of
10 Feb 2025
Net transactions value
-$95,502
Form type
4
Filing time
12 Feb 2025, 17:47:12 UTC
Previous filing
10 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +2,272 +18% $0.000000 14,725 10 Feb 2025 Direct
transaction BIIB Common Stock Tax liability $95,502 -670 -4.5% $142.54 14,055 10 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -2,272 -100% $0.000000 0 10 Feb 2025 Common Stock 2,272 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.